The pills of last resort; How dying patients get access to experimental drugs

Darshak Sanghavi, M.D. / New York Times

It was shortly after the breadbasket arrived last year at the Temple Bar near Harvard Square that Sarah Broom first told me about the last-ditch plan to save her own life.

Letter
to the
Editor

Send us a letter

Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

Recommended for You
U.S. Food and Drug Administration (FDA)
Upcoming FDA draft on pulse oximetry's racial bias draws questions
Most Popular
1
Why systems are pumping billions of dollars into outpatient care
2
Inside UnitedHealth's playbook to deny mental health coverage
3
Former CVS Health exec joins WellBe Senior Medical
4
UnitedHealth, Centene get Medicare Advantage Star Rating upgrades
5
GE Healthcare to acquire full stake in Nihon Medi-Physics